Full Name
Laura Bukavina
Job Title
Urologic Oncologist
Company
University Hospitals Cleveland Medical Center, Case Western Reserve
Speaker Bio
Dr. Bukavina is a recipient of multiple grants and awards for her dedication to bladder and kidney cancer research, including the Robert Wood Johnson Foundation Health Data for Action, Bladder Cancer Advocacy Network Young Investigator, American Urologic Association (AUA) Research Scholar and Society of Women in Urology (SWIU) Elizabeth Pickett Award. She has been recognized for her research evaluating interplay between genetics, microbiome and tumor microenvironment. Further, her recognition by the American Association of Cancer Research (AACR) as one of the Top Women in Cancer Research underscores her standing as a pioneering figure among women cancer surgeon scientists.
Dr. Bukavina was born in Ukraine and raised in Cleveland. She earned her medical degree at Northeast Ohio Medical University, her Master of Epidemiology at Johns Hopkins and her Master of Immunology at Drexel University. She completed her urologic residency training at Case Western Reserve University and UH, followed by prestigious fellowship in urologic oncology at Fox Chase Cancer Center. Dr. Bukavina's research strikes a delicate balance between exploring the vast potential of the microbiome and revolutionizing cancer treatment. In addition to surgeon scientist role, Dr. Bukavina is an associate editor for European Urology, a Society of Urologic Oncology (YOU) board member, and a member of the Urology Times editorial board – all focused on advancing the surgical and scientific frontier of urologic oncology and clinical trial development.
Dr. Bukavina was born in Ukraine and raised in Cleveland. She earned her medical degree at Northeast Ohio Medical University, her Master of Epidemiology at Johns Hopkins and her Master of Immunology at Drexel University. She completed her urologic residency training at Case Western Reserve University and UH, followed by prestigious fellowship in urologic oncology at Fox Chase Cancer Center. Dr. Bukavina's research strikes a delicate balance between exploring the vast potential of the microbiome and revolutionizing cancer treatment. In addition to surgeon scientist role, Dr. Bukavina is an associate editor for European Urology, a Society of Urologic Oncology (YOU) board member, and a member of the Urology Times editorial board – all focused on advancing the surgical and scientific frontier of urologic oncology and clinical trial development.
Speaking At